Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 457-080-9 | CAS number: 32940-15-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 03-AUG-2005 - 17-AUG-2005
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 005
- Report date:
- 2005
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- 24 April 2002
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- 29 April 2004
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- (except the pre-test) (d.d. march 2003)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- -
- EC Number:
- 457-080-9
- EC Name:
- -
- Cas Number:
- 32940-15-1
- Molecular formula:
- C11H12O2
- IUPAC Name:
- 5-methoxy-1,2,3,4-tetrahydronaphthalen-2-one
- Test material form:
- solid: compact
- Details on test material:
- - Description: White-yellowish solid
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- other: CBA/CaHsdRcc
- Sex:
- female
- Details on test animals and environmental conditions:
- - Source: RCC Ltd, Laboratory Animal Service, CH-4414 Füllinsdorf, Switzerland
- Age at study initiation: 8 - 12 weeks (beginning of acclimatization)
- Weight at study initiation (main study): 19.1 g - 22.0 g
- Housing: Animals were individually housed in Makrolon type-2 cages
- Diet: Free access to pelleted rodent diet (Pelleted standard Kliba 3433 from Provimi Kliba AG, CH-4303 Kaiseraugst)
- Water: Free access to tap water
- Acclimation period: 7 days
ENVIRONMENTAL CONDITIONS (set conditions)
- Temperature (°C): 19 – 25
- Humidity (%): 30 - 70
- Air changes (per hr): 10 - 15
- Photoperiod (hrs dark / hrs light): 12/12
Study design: in vivo (LLNA)
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 0, 2.5, 5 and 10% (w/v)
- No. of animals per dose:
- 4
- Details on study design:
- RANGE FINDING TESTS
In a pre-test, test substance concentrations of 5, 10, 25 and 50% were tested in two mice. Each concentration was tested on one ear, by a single application.
MAIN STUDY
ANIMAL ASSIGNMENT
Three groups of four animals were treated with one test substance concentration per group. One group of four animals was treated with vehicle.
TREATMENT PREPARATION AND ADMINISTRATION
- Test substance preparation: The whole sample was melted under nitrogen protection at 87 °C ± 2 °C in a water-bath to get a liquid homogenous sample. After thorough shaking the test item was placed into a volumetric flask on a tared Mettler balance, and vehicle was quantitatively added. The weight/volume (w/v) dilutions were prepared individually using a magnetic stirrer as homogenizer. Test item formulations were made freshly before each dosing occasion and no more than 4 hours prior to application to the ears. Homogeneity of the test item in the vehicle was maintained during treatment with the magnetic stirrer.
- Rationale for vehicle: The vehicle was selected based on trial formulations
Performed according to test guidelines:
- Days 1, 2 and 3: Induction (topical treatment of 25 µL/ear)
- Day 6: Injection of 20.4 µCi 3H-methyl thymidine.
Five hours after the injection, all animals were euthanized and the ear lymph nodes were excised and pooled for each experimental group. Single cell suspensions (phosphate buffered saline) of pooled lymph node cells were prepared by gentle mechanical disaggregation through stainless steel gauze (200 μm mesh size). After washing twice with phosphate buffered saline (approx. 10 ml) the lymph node cells were resuspended in 5 % trichloroacetic acid (approx. 3 ml) and incubated at approximately +4 °C for at least 18 hours for precipitation of macromolecules. The precipitates were then resuspended in 5 % trichloroacetic acid (1 ml) and transferred to glass scintillation vials with 10 ml of ‘Irga-Safe Plus’ scintillation liquid and thoroughly mixed.
- Day 7: Radioactivity measurements
Observations:
Mortality/Viability: Once daily from acclimatization start to Day 6
Body weights: On Day 1 (pre-dose) and Day 6 (prior to necropsy).
Clinical signs and irritation: Once daily on the day of animals delivery and from Days 1 (pre-dose) to Day 6
INTERPRETATION
- Criteria used to consider a positive response: DPM values are presented for each dose group (8 nodes). A Stimulation Index (SI) is calculated for each group. The SI is the ratio of the DPM/group compared to DPM/vehicle control group. If the results indicate a SI ≥ 3, the test substance may be regarded as a skin sensitizer. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
Results and discussion
- Positive control results:
- The reliability check with Alpha-hexylcinnamicaldehyde indicated that the Local Lymph Node Assay as performed at RCC Ltd is an appropriate model for testing for contact hypersensitivity. The SI values calculated for the concentrations 5, 10 and 25% were 2.9, 3.9 and 8.7, respectively. An EC3 value of 5.5% was calculated.
In vivo (LLNA)
Resultsopen allclose all
- Key result
- Parameter:
- SI
- Value:
- 7.2
- Test group / Remarks:
- Test substance concentration of 2.5%
- Key result
- Parameter:
- SI
- Value:
- 14.9
- Test group / Remarks:
- Test substance concentration of 5%
- Key result
- Parameter:
- SI
- Value:
- 22.1
- Test group / Remarks:
- Test substance concentration of 10%
- Cellular proliferation data / Observations:
- CELLULAR PROLIFERATION DATA
The size of the draining lymph nodes of the test substance groups was 2 to 4-fold larger compared to those of the control group.
DETAILS ON STIMULATION INDEX CALCULATION
Mean DPM values for the experimental groups treated with test substance concentrations 2.5, 5 and 10% were 29985, 62299 and 92456 DPM respectively. The mean DPMl value for the vehicle control group was 4182 DPM.
EC3 CALCULATION
An EC3 value could not be determined because this calculation requires a S.I. value of less than 3.
CLINICAL OBSERVATIONS
No mortality occurred.
No clinical signs were observed in any animals of the control group or Group 2 (2.5 %). On the second application day, a slight ear erythema was observed at both dosing sites in all mice of Group 3 (5 %) and Group 4 (10 %) (for Group 4, a moderate erythema was found on Day 4), persisting for the remainder of the in-life phase of the study (Group 4) or persisting for a total of three days (Group 3). On Day 6, scattered pinhead large lesion was observed at both dosing sites in all mice of Group 4 (10 %).
BODY WEIGHTS
The body weight of the animals, recorded prior to the first application and prior to necropsy, was within the range commonly recorded for animals of the strain and age.
Any other information on results incl. tables
Results pre-test
No effects were observed at 10%. One day after the application, a moderate ear erythema was noted at 25 and 50%.
Based on these results, the highest test substance concentration selected for the main study was a 10% concentration.
Applicant's summary and conclusion
- Interpretation of results:
- other: Category 1 (skin sensitising) based on GHS and CLP criteria
- Conclusions:
- In an LLNA skin sensitisation study, performed according to OECD 429 (2002) and according to GLP principles, the substance was considered to be a skin sensitiser, as the SI was shown to be >= 3 when tested up to and including 10%.
- Executive summary:
An LLNA skin sensitisation study was performed according to OECD 429 (2002) and according to GLP principles with the substance. Reliable positive and negative controls were included. Based on the results of a pre-screen test, three experimental groups of four female mice were treated with test substance concentrations of 2.5, 5 or 10% (w/v) on three consecutive days, by open application on the ears. Four vehicle control animals were similarly treated, but with vehicle alone (acetone/olive oil (4:1 v/v)). No clinical signs were observed in any animals of the control group or Group 2 (2.5 %). On the second application day, a slight ear erythema was observed at both dosing sites in all mice of Group 3 (5 %) and Group 4 (10 %) (for Group 4, a moderate erythema was found on Day 4), persisting for the remainder of the in-life phase of the study (Group 4) or persisting for a total of three days (Group 3). On Day 6, scattered pinhead large lesion was observed at both dosing sites in all mice of Group 4 (10 %). The size of the draining lymph nodes of the test substance groups was 2 to 4-fold larger compared to those of the control group. Mean DPM values for the experimental groups treated with test substance concentrations 2.5, 5 and 10% were 29985, 62299 and 92456 DPM, respectively. The mean DPMl value for the vehicle control group was 4182 DPM. The SI values calculated for the substance concentrations 2.5, 5 and 10% were 7.2, 14.9 and 22.1, respectively. Based on these data, the substance is considered to be a skin sensitiser, as the SI was shown to be >= 3 when tested up to and including 10%. The substance needs to be classified as skin sensitiser (Category 1) according to GHS and CLP. As an EC3 value could not be determined (and the lowest tested substance concentration was 2.5%), the available data are not sufficient for sub-categorisation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.